source name	characteristics[organism]	characteristics[organism part]	characteristics[strain/breed]	characteristics[developmental stage]	Characteristics[disease]	characteristics[sex]	characteristics[ancestry category]	characteristics[age]	Characteristics[cultured cell]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[individual]	Characteristics[biological replicate]	Material Type	assay name	Technology Type	comment[file]	comment[label]	comment[fractionation method]	comment[fraction identifier]	comment[ms2 mass analyzer]	comment[instrument]	comment[separation]	comment[file uri]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 1	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc1 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 2	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 3	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 4	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 5	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 6	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 7	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 8	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 9	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 10	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc2 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 11	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 12	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 13	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 14	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 15	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 16	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc3 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 17	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc4 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 18	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc5 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 19	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 20	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 21	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 22	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 23	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 24	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 25	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 26	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 27	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 28	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 29	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 30	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 31	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 32	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 33	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 34	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 35	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 36	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 37	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 38	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 39	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 40	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 41	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 42	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 43	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 44	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 45	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 46	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 47	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 48	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 49	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 50	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 51	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 52	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 53	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 54	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 55	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 56	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 57	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 58	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 59	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 60	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 61	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 62	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 63	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 64	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 65	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 66	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 67	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 68	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 69	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 70	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 71	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 72	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 73	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 74	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 75	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 76	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 77	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 78	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 79	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 80	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 81	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 82	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 83	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 84	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 85	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 86	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 87	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 88	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 89	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 90	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 91	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 92	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 93	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 94	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 95	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 96	proteomic profiling by mass spectrometry	20161017_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 97	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 98	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F10_170503153643.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 99	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 100	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 101	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 102	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 103	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 104	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 105	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 106	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 107	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 108	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 109	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 110	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 111	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 112	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 113	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 114	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 115	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 116	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 117	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 118	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 119	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1		run 120	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 121	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F1_170427224508.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 122	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 123	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 124	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 125	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 126	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 127	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 128	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 129	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 130	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 131	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 132	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F2_170427235251.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 133	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 134	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 135	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 136	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 137	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 138	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F3_170428010030.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 139	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F4_170428020817.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 140	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 141	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 142	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 143	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1		run 144	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 145	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 146	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 147	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 148	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 149	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 150	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 151	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 152	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 153	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 154	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 155	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 156	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 157	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 158	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 159	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 160	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 161	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 162	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 163	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 164	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 165	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 166	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 167	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1		run 168	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	1		run 169	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_1_A1_170407145349.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	1		run 170	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	1		run 171	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	1		run 172	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	1		run 173	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_13_B1_170410214309.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	1		run 174	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_14_B2_170410172255.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	1		run 175	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	1		run 176	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	1		run 177	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_17_B5_170410193253.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	1		run 178	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_18_B6_170411020408.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	1		run 179	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	1		run 180	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_2_A2_170411115256.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	1		run 181	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	1		run 182	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	1		run 183	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	1		run 184	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_23_B11_170411083623.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	1		run 185	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_24_B12_170411005852.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	1		run 186	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	1		run 187	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_26_C2_170411182553.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	1		run 188	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	1		run 189	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	1		run 190	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_3_A3_170410151303.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	1		run 191	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	1		run 192	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_31_C6_170410140811.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	1		run 193	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_32_C7_170410130315.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	1		run 194	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_33_C8_170410235334.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	1		run 195	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	1		run 196	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	1		run 197	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	1		run 198	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_37_C12_170411193130.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	1		run 199	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	1		run 200	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_39_D2_170411041450.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	1		run 201	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	1		run 202	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease		not available	62	not available	not available	not available	41	1		run 203	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	1		run 204	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	1		run 205	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	1		run 206	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	1		run 207	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	1		run 208	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_46_D9_170407155901.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	1		run 209	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	1		run 210	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	1		run 211	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_49_D12_170411030928.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	1		run 212	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	1		run 213	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_50_E1_170410203801.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	1		run 214	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	1		run 215	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_52_E3_170410224820.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	1		run 216	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	1		run 217	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	1		run 218	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	1		run 219	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_56_E7_170410182751.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	1		run 220	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	1		run 221	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_58_E9_170411161451.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	1		run 222	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_59_E10_170411073057.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	1		run 223	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	1		run 224	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	1		run 225	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1		run 226	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	1		run 227	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_63_F2_170410161757.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	1		run 228	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	1		run 229	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	1		run 230	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_66_F5_170411094153.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	1		run 231	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	1		run 232	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	1		run 233	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	1		run 234	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_7_A7_170411140356.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	1		run 235	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	1		run 236	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_71_F10_170411150921.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	1		run 237	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_72_F11_170411104724.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	1		run 238	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	1		run 239	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_74_G1_170410115825.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	1		run 240	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_75_G2_170411062533.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	1		run 241	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_76_G3_170411052011.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	1		run 242	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	1		run 243	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_78_G5_170411172027.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	1		run 244	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	1		run 245	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_9_A9_170411125828.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	2		run 246	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	2		run 247	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	2		run 248	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	2		run 249	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	2		run 250	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	2		run 251	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	2		run 252	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	2		run 253	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	2		run 254	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	2		run 255	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	2		run 256	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	2		run 257	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	2		run 258	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	2		run 259	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	2		run 260	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	2		run 261	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	2		run 262	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	2		run 263	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	2		run 264	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	2		run 265	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	2		run 266	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	2		run 267	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	2		run 268	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	2		run 269	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	2		run 270	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	2		run 271	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_33_C8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	2		run 272	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	2		run 273	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	2		run 274	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	2		run 275	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	2		run 276	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	2		run 277	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	2		run 278	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	2		run 279	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease		not available	62	not available	not available	not available	41	2		run 280	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	2		run 281	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	2		run 282	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	2		run 283	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	2		run 284	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	2		run 285	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	2		run 286	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	2		run 287	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	2		run 288	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	2		run 289	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	2		run 290	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	2		run 291	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	2		run 292	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	2		run 293	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	2		run 294	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	2		run 295	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	2		run 296	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	2		run 297	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	2		run 298	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	2		run 299	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	2		run 300	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	2		run 301	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	2		run 302	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	2		run 303	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	2		run 304	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	2		run 305	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	2		run 306	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	2		run 307	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	2		run 308	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	2		run 309	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	2		run 310	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	2		run 311	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	2		run 312	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	2		run 313	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	2		run 314	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	2		run 315	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	2		run 316	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	2		run 317	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	2		run 318	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	2		run 319	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	2		run 320	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	2		run 321	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	2		run 322	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	3		run 323	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	3		run 324	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	3		run 325	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	3		run 326	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	3		run 327	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	3		run 328	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	3		run 329	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	3		run 330	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	3		run 331	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	3		run 332	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	3		run 333	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_19_B7_170418185445.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	3		run 334	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	3		run 335	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	3		run 336	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	3		run 337	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	3		run 338	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	3		run 339	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	3		run 340	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	3		run 341	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	3		run 342	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	3		run 343	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	3		run 344	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	3		run 345	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	3		run 346	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	3		run 347	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	3		run 348	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_33_C8_170420120643.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	3		run 349	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	3		run 350	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	3		run 351	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	3		run 352	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	3		run 353	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	3		run 354	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	3		run 355	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	3		run 356	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease		not available	62	not available	not available	not available	41	3		run 357	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	3		run 358	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	3		run 359	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	3		run 360	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	3		run 361	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	3		run 362	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	3		run 363	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	3		run 364	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	3		run 365	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	3		run 366	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	3		run 367	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	3		run 368	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	3		run 369	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	3		run 370	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	3		run 371	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	3		run 372	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	3		run 373	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	3		run 374	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	3		run 375	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	3		run 376	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	3		run 377	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	3		run 378	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	3		run 379	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	3		run 380	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	3		run 381	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	3		run 382	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	3		run 383	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	3		run 384	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	3		run 385	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	3		run 386	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	3		run 387	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	3		run 388	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	3		run 389	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	3		run 390	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	3		run 391	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	3		run 392	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	3		run 393	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	3		run 394	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	3		run 395	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	3		run 396	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	3		run 397	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	3		run 398	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	3		run 399	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	
